Related Experiment Video
Updated: May 5, 2026
04:16
Whole Body Vibration Methods with Survivors of Polio
Published on: October 17, 2018
14.2K
Thyrotoxic periodic paralysis: diversity in America
Hetain Patel1, Lina Vanessa Wilches1, Jorge Guerrero1
1Division of Critical Care and Pulmonary Diseases, Florida Hospital Orlando, Orlando, Florida.
The Journal of Emergency Medicine
|December 10, 2013
Summary
Thyrotoxic periodic paralysis (TPP) is a serious condition causing muscle paralysis due to hyperthyroidism. Prompt recognition, especially in young Asian males, is crucial for emergency physicians to prevent fatalities.
Area of Science:
- Endocrinology
- Neurology
- Emergency Medicine
Background:
- Thyrotoxic periodic paralysis (TPP) is a rare but dangerous complication of thyrotoxicosis.
- It presents with hypokalemia and muscle paralysis, often overlooked in Western countries.
- Subtle thyrotoxic symptoms can delay diagnosis.
Observation:
- A 23-year-old Vietnamese male experienced sudden quadriplegia and chest tightness.
- Laboratory results showed critically low potassium (1.4 mmol/L).
- Further investigations confirmed thyrotoxicosis, leading to a TPP diagnosis.
Findings:
- The case highlights TPP as a critical differential diagnosis in patients with paralysis.
- Young males of Asian descent are particularly at risk.
- Early identification of thyrotoxicosis is key.
Implications:
- Emergency physicians must consider TPP in patients with paralysis, especially those with risk factors.
- Timely diagnosis and treatment of TPP can prevent mortality.
- Increased awareness of TPP is needed in non-Asian populations.
Related Concept Videos
01:24Graves Disease II: Pathophysiology
26
Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor,...
26
01:28Graves' Disease I: Introduction
23
Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence...
23
01:27Hyperthyroidism II: Pathophysiology
28
Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH...
28
01:12Alterations in Muscle Tone ll
27
Alterations in muscle tone are common manifestations of neurological disorders and reflect dysfunction within different nervous system regions. Spasticity, paratonia, and dystonia represent distinct forms of hypertonia, each with unique mechanisms, clinical features, and diagnostic importance.CharacteristicsSpasticity happens from upper motor neuron lesions and is characterized by velocity-dependent resistance to passive movement. Clinical features include:Exaggerated deep tendon reflexesClonus...
27
01:25Hyperthyroidism I: Introduction
30
Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
30
01:22Myasthenia Gravis ll: Pathophysiology
53
The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
53